Encephalitis Panel with Reflex to Herpes Simplex Virus Types 1 and 2 Glycoprotein G-Specific Antibodies, IgG, Serum
2008915
 
Ordering Recommendation
Mnemonic
ENCEPH
Methodology
Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Semi-Quantitative Chemiluminescent Immunoassay
Performed
Sun-Sat
Reported
2-6 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Serum separator tube.  
Specimen Preparation
Transfer 3 mL serum to an ARUP Standard Transport Tube. (Min: 1.5 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Refer to individual components. CSF (refer to Encephalitis Panel with Reflex to Herpes Simplex Virus Types 1 and 2 Glycoprotein G-Specific Antibodies, IgG, CSF, test code 2008916).  
Remarks
 
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year  
Reference Interval
Test Number Components Reference Interval
0050380Measles (Rubeola) Antibody, IgG Effective August 20, 2012

24.9 AU/mL or less: Negative -​ No significant level of detectable measles (rubeola) IgG antibody.
25.0-​29.9 AU/mL: Equivocal -​ Repeat testing in 10-​14 days may be helpful.
30.0 AU/mL or greater: Positive -​ IgG antibody to measles (rubeola) detected, which may indicate a current or past exposure/immunization to measles (rubeola).
0099597Measles (Rubeola) Antibody, IgM 0.79 AU or less: Negative -​ No significant level of IgM antibodies to measles (rubeola) virus detected.
0.80-​1.20 AU: Equivocal -​ Repeat testing in 10-​14 days may be helpful.
1.21 AU or greater: Positive -​ IgM antibodies to measles (rubeola) virus detected. Suggestive of current or recent infection or immunization. However, low levels of IgM antibodies may occasionally persist for more than 12 months post-​infection or immunization.
0050390Mumps Virus Antibody, IgG Effective August 20, 2012

8.9 AU/mL or less: Negative -​ No significant level of detectable IgG mumps virus antibody.
9.0-​10.9 AU/mL: Equivocal -​ Repeat testing in 10-​14 days may be helpful.
11.0 AU/mL or greater: Positive -​ IgG antibody to mumps virus detected, which may indicate a current or past exposure/immunization to mumps virus.
0099589Mumps Virus Antibody, IgM 0.79 IV or less: Negative -​ No significant level of detectable IgM antibody to Mumps virus.
0.80-​1.20 IV: Equivocal -​ Borderline levels of IgM antibody to Mumps virus. Repeat testing in 10-​14 days may be helpful.
1.21 IV or greater: Positive -​ Presence of IgM antibody to Mumps virus detected, which may indicate a current or recent infection. However, low levels of IgM antibody may occasionally persist for more than 12 months post-​infection or immunization.
0050167Varicella-​Zoster Virus Antibody, IgG Effective August 20, 2012

134 IV or less: Negative -​ No significant level of detectable varicella-​zoster IgG antibody.
135-​165 IV: Equivocal -​ Repeat testing in 10-​14 days may be helpful.
166 IV or greater: Positive -​ IgG antibody to varicella-​zoster detected, which may indicate a current or past varicella-​zoster infection.
0099314Varicella-​Zoster Virus Antibody, IgM 0.90 ISR or less: Negative -​ No significant level of detectable varicella-​zoster virus IgM antibody.
0.91-​1.09 ISR: Equivocal -​ Repeat testing in 10-​14 days may be helpful.
1.10 ISR or greater: Positive -​ Significant level of detectable varicella-​zoster virus IgM antibody. Indicative of current or recent infection. However, low levels of IgM antibodies may occasionally persist for more than 12 months post-​infection or immunization.
0050641Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgM by ELISA
0.89 IV or less: Not Detected.
0.90-​1.09 IV: Indeterminate -​ Repeat testing in 10-​14 days may be helpful.
1.10 IV or greater: Detected -​ IgM antibody to HSV detected, which may indicate a current or recent infection. However, low levels of IgM antibodies may occasionally persist for more than 12 months post-​infection.
0050292Herpes Simplex Virus Type 1 Glycoprotein G-​Specific Antibody, IgG by CIA
Effective February 18, 2014
0.90 IV or less Negative -​ No significant level of detectable IgG antibody to HSV type 1 glycoprotein G.
0.91-​1.09 IV Equivocal -​ Questionable presence of IgG antibody to HSV type 1 glycoprotein G. Repeat testing in 10-​14 days may be helpful.
1.10 IV or greater Positive -​ IgG antibody to HSV type 1 glycoprotein G detected, which may indicate a current or past HSV infection.
0050294Herpes Simplex Virus Type 2 Glycoprotein G-​Specific Antibody, IgG by CIA
Effective February 18, 2014
0.90 IV or less Negative -​ No significant level of detectable IgG antibody to HSV type 2 glycoprotein G.
0.91-​1.09 IV Equivocal -​ Questionable presence of IgG antibody to HSV type 2 glycoprotein G. Repeat testing in 10-​14 days may be helpful.
1.10 IV or greater Positive -​ IgG antibody to HSV type 2 glycoprotein G detected, which may indicate a current or past HSV infection.
0050293Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG
0.89 IV or less: Not Detected.
0.90-​1.09 IV: Indeterminate -​ Repeat testing in 10-​14 days may be helpful.
1.10 IV or greater: Detected.
0050234West Nile Virus Antibody, IgG by ELISA, Serum 1.29 IV or less: Negative -​ No significant level of West Nile virus IgG antibody detected.
1.30-​1.49 IV: Equivocal -​ Questionable presence of West Nile virus IgG antibody detected. Repeat testing in 10-​14 days may be helpful.
1.50 IV or greater: Positive -​ Presence of IgG antibody to West Nile virus detected, suggestive of current or past infection.
0050236West Nile Virus Antibody, IgM by ELISA, Serum 0.89 IV or less: Negative -​ No significant level of West Nile virus IgM antibody detected.
0.90-​1.10 IV: Equivocal -​ Questionable presence of West Nile virus IgM antibody detected. Repeat testing in 10-​14 days may be helpful.
1.11 IV or greater: Positive -​ Presence of IgM antibody to West Nile virus detected, suggestive of current or recent infection.
Interpretive Data
Note
If HSV 1 and/or 2 IgG is 1.10 IV or greater, then HSV 1 G-Specific IgG and HSV 2 G-Specific IgG will be added. Additional charges apply.
CPT Code(s)
86765 x2; 86735 x2; 86787 x2; 86789; 86788; 86694 x2; if reflexed, add 86695; 86696
Components
Component Test Code*Component Chart Name
0050167Varicella-Zoster Virus Ab, IgG
0050234West Nile Virus Ab, IgG, Ser
0050236West Nile Virus Ab, IgM, Ser
0050286HSV Type 1/2 Combined Ab, IgG
0050380Measles, Rubeola, Antibody IgG
0050390Mumps Virus Antibody, IgG
0050641HSV 1 and/or 2 Abs, IgM by ELISA
0099314Varicella-Zoster Virus Antibody, IgM
0099589Mumps Virus Antibody, IgM
0099597Measles, Rubeola, Antibody IgM
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References